THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate ...

For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.

New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors detect and track cancerous cells. Prostate cancer is the most common cancer ...

In a study involving more than 11,000 men enrolled in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial, about one quarter of elevated prostate-specific antigen (PSA) results ...

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

Current prostate specific antigen (PSA) testing "may not effectively target testing to those most likely to benefit, raising concerns about overtesting" warn researchers from the University of Oxford ...

State-funded clinical study will validate the OTraces’ proteomic blood test ability to reduce unnecessary prostate biopsies in men with elevated PSADEERFIELD BEACH, Fla., June 25, 2026 (GLOBE NEWSWIRE ...